Boehringer Ingelheim Corporation FY Profit Slumps 50 Pct, Hit by Generics
(Reuters) - Boehringer Ingelheim, the world's largest unlisted drugmaker, saw net income slump by half in 2010 as cheaper generic copies of some of its best-selling pharmaceuticals came to market.